• Home
  • Mappa
  • Xagena
    • News (IT)
    • News (EN)
    • MedicinaNews
    • MedicineNews
    • Mappa
    • Partner
  • Cardiologia
    • News
    • Farmaci
    • Focus
  • Oncologia
    • News
    • Farmaci
    • Focus
    • Oncoimmunoterapia
  • OncoHub
    • OncoDermatologia
    • OncoEmatologia
    • OncoGastroenterologia
    • OncoGeriatria
    • OncoGinecologia
    • OncoNeurologia
    • OncoPneumologia
    • OncoTerapia
    • OncoUrologia
    • UrologiaOncologica
  • Neurologia
    • News
    • Farmaci
    • Focus
  • Specialità
    • Allergologia
    • Andrologia
    • Angiologia
    • Aritmologia
    • Cardiologia
    • Dermatologia
    • Diabetologia
    • Ematologia
    • Endocrinologia
    • Epatologia
    • Gastroenterologia
    • Ginecologia
    • Infettivologia
    • Metabolismo
    • Nefrologia
    • Neurologia
    • Oculistica
    • Oncologia
    • Pediatria
    • Pneumologia
    • Psichiatria
    • Reumatologia
    • Urologia
    • Virologia
  • Patologie
    • Aids
    • Allergie
    • Alzheimer
    • Angina pectoris
    • Ansia
    • Aritmie
    • Artrite
    • Asma
    • Calvizie
    • Cefalea
    • Celiachia
    • Colite ulcerosa
    • Crohn
    • Depressione
    • Diabete mellito
    • Disturbo bipolare
    • Dolore
    • Epatite
    • Epilessia
    • Fibrillazione atriale
    • Glaucoma
    • Ictus
    • Infarto miocardico
    • Insonnia
    • Ipercolesterolemia
    • Ipertensione
    • Ipertiroidismo
    • Iperplasia prostatica
    • Ipotiroidismo
    • Lupus
    • Malattie rare
    • Micosi
    • Osteoporosi
    • Parkinson
    • Psoriasi
    • Rosacea
    • Schizofrenia
    • Sclerosi multipla
    • Scompenso cardiaco
    • Tossicodipendenze
    • Trombosi
  • Database
    • MediExplorer.it
    • FarmaExplorer.it
    • CardioBase.it
    • DermaBase.it
    • EmatoBase.it
    • FarmAlert.it
    • FarmaPedia.it
    • GastroBase.it
    • MedFocus.it
    • MediLine.it
    • MedPedia.it
    • NeuroBase.it
    • OncoBase.it
    • PneumoBase.it
    • ReumaBase.it
    • Xapedia.it
  • Farmaci
    • News
    • Farmacia
    • Farmacologia
    • Farmacovigilanza
    • Vaccini
  • Forum
    • Forum Cardiologico
    • Forum Ematologico
    • Forum Neurologico
    • Forum Oncologico
    • Forum Pneumologico
    • MediLearn
    • MediExpert
  • Salute
    • Xagena Salute
  • english
  • Specialities
    • Allergology
    • Andrology
    • Cardiology
    • Dermatology
    • Diabetology
    • Diagnostics
    • Endocrinology
    • Gastroenterology
    • Genemedicine
    • Gynecology
    • Hematology
    • Hepatology
    • Infectivology
    • Metabolism
    • Nephrology
    • Neurology
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharmacology
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Urology
    • Vaccines
    • Virology
  • Database
    • MediExplorer.net
    • MedPedia.net
    • Xapedia.net

Medicine Drugs

Medicine - Xagena Medical News

Newsletter Xagena

Aggiornamento in Medicina

Iscrizione Free

Maintenance Rituximab is useful for advanced indolent lymphoma

A new study has found for the first time that maintenance therapy with the novel antibody, Rituximab ( MabThera, Rituxan ...
Leggi articolo

Immune thrombocytopenic purpura: Eltrombopag boosts platelets

Patients suffering from a blood disorder that prevents proper clotting have the option of a new medication that may dramatically ...
Leggi articolo

Rheumatoid arthritis: patients who fails to respond to initial treatment with Rituximab can still be successfully re-treated with a second course of drug

Rheumatoid arthritis patients who failed to respond to initial treatment with Rituximab ( MabThera, Rituxan ) ( a chimeric monoclonal ...
Leggi articolo

Graves' orbitopathy: Rituximab is effective after steroids fail

A small group of patients with severe Graves' eye disease experienced rapid improvement of their symptoms — and improved vision ...
Leggi articolo

Aggressive inflammatory breast cancer: treatment with Lapatinib

Lapatinib ( Tykerb ) could be used to treat inflammatory breast cancer, an aggressive from of the disease which represents ...
Leggi articolo

Metastatic HER2+ breast cancer: triple drug combination is promising option

Combining two chemotherapy drugs with Trastuzumab ( Herceptin ) to treat women who have metastatic HER2+ breast cancer may offer ...
Leggi articolo

Diclofenac linked to high risk of cardiovascular deaths among healthy people

Some nonsteroidal anti-inflammatory drugs ( NSAIDs ) are associated with significantly higher risks of dying from heart-related causes among healthy ...
Leggi articolo

Low-dose Acetylsalicylic Acid may benefit older people with diabetes at high cardiovascular risk ( 2010 )

Low-dose Acetylsalicylic Acid ( Aspirin ) therapy is a reasonable measure to prevent a first myocardial infarction or stroke among ...
Leggi articolo

HEAAL Study: higher dose of Losartan significantly reduced deaths and hospitalizations due to heart failure

In an investigational study, Losartan ( Cozaar ) 150 mg, administered once daily, significantly reduced the risk of all-cause death ...
Leggi articolo

Antipsychotic drugs: use of Olanzapine by children and adolescents associated with high weight gain

Many pediatric and adolescent patients who received second-generation antipsychotic medications experienced significant weight gain, along with varied adverse effects on ...
Leggi articolo

Antipsychotics may contribute to inflammatory processes

The treatment with a number of antipsychotic medications is associated with weight gain, and for some, hyperglycemia and hyperlipidemia. This cluster ...
Leggi articolo

Schizophrenia: Clozapine is associated with lower mortality, Quetiapine with the highest risk

A new study has shown that use of Clozapine ( Clozaril, Leponex ) is associated with lower mortality (by 26%), ...
Leggi articolo

Pazopanib in treating patients with aggressive thyroid cancer

Mayo investigators reported that cancer in about two-thirds of 37 patients with aggressive differentiated thyroid cancer treated with the drug ...
Leggi articolo

Acute coronary syndromes: Ticagrelor is the first antiplatelet agent to demonstrate a reduction in cardiovascular death

The PLATO ( A Study of Platelet Inhibition and Patient Outcomes ) trial showed that Ticagrelor ( Brilinta ) has ...
Leggi articolo

Angioplasty: high-dose Clopidogrel combined with usual doses of Acetylsalicylic Acid may be an optimal treatment strategy

A study led by McMaster University researchers found high doses of Clopidogrel ( Plavix ) significantly reduce complications in heart ...
Leggi articolo

Myocardial infarction: patients treated with more antithrombotic drugs have increased risk of hospital admission for bleeding

In patients with myocardial infarction, risk of hospital admission for bleeding increases with the number of antithrombotic drugs used. Patients ...
Leggi articolo

Juvenile idiopathic arthritis: treatment with Etanercept

Three studies have shown the anti-TNF ( Tumour Necrosis Factor ) therapy Etanercept ( Enbrel ) to be effective, with ...
Leggi articolo

Risk of tuberculosis with anti-TNF agents

Treatment with anti-tumor necrosis factor ( TNF ) agents is recognized as a risk factor for tuberculosis in patients with ...
Leggi articolo

Advanced kidney cancer: Sunitinib shows promising results in patients with poor prognosis

Sunitinib ( Sutent ) prolongs progression-free and overall survival, and is safe and well tolerated in advanced kidney cancer ( ...
Leggi articolo

Cetuximab increases survival in patients with head and neck cancer for up to 5 years

Adding Cetuximab ( Erbitux ) to radiation therapy prolongs survival in patients with locally advanced head and neck cancer compared ...
Leggi articolo

Chronic myeloid leukemia: Nilotinib and Dasatinib evoke faster response than Imatinib

Two medications approved as treatment for drug-resistant chronic myeloid leukemia ( CML ) continue to provide patients with quicker, better ...
Leggi articolo

Bevacizumab controls macular edema related to diabetes and to cataract surgery

Ophthalmology, the journal of the American Academy of Ophthalmology, reports on use of Avastin ( Bevacizumab ), to benefit diabetic ...
Leggi articolo

Colorectal cancer: new treatments offer better survival

Colorectal cancer is the second leading cause of cancer-related death in the Western world. Physicians today have an abundance of ...
Leggi articolo

Bevacizumab dramatically improves response, survival in recurrrent glioblastoma

The targeted therapy Avastin ( Bevacizumab ), alone and in combination with the chemotherapy drug CPT-11, significantly increased response rates, ...
Leggi articolo

Breast cancer survival improves using Herceptin with chemotherapy

Using Herceptin ( Trastuzumab ) with chemotherapy, instead of after, clearly improves treatment of women with HER2+ breast cancer, and ...
Leggi articolo

Anemia: stroke risk from Aranesp

The use of Darbepoetin alfa ( Aranesp ) in patients with diabetes, chronic kidney disease, and moderate anemia who were ...
Leggi articolo

Potential risk of male breast cancer with Finasteride

Finasteride is an inhibitor of type II 5-alpha-reductase, an enzyme that metabolises testosterone into the more potent androgen, dihydrotestosterone ( ...
Leggi articolo

Removab for treatment of malignant ascites

The European Commission has approved Removab ( Catumaxomab ) for the treatment of malignant ascites. The approval is based on ...
Leggi articolo

Catumaxomab well tolerated in treatment of gastric cancer

A Phase II study with the trifunctional antibody Catumaxomab ( Removab ) in the treatment of patients with gastric cancer ...
Leggi articolo

Long-term data for Odanacatib: positive results in treating osteoporosis

New data from a Phase IIB clinical study of Odanacatib, oral, once-weekly investigational treatment for osteoporosis, showed that when stopping ...
Leggi articolo

Insulin glargine, possible cancer link

Insulin glargine ( Lantus ) is a long-acting insulin analogue, an Insulin molecule that has been modified for more sustained ...
Leggi articolo

Raxibacumab for treatment of inhalation anthrax disease

Human Genome Sciences has announced the results of two pivotal animal efficacy studies, which showed the life-saving potential of the ...
Leggi articolo

Hypercholesterolemia: Pitavastatin is non-inferior to Atorvastatin and Simvastatin

New phase III data demonstrated that Pitavastatin ( Livalo ) is non-inferior to Atorvastatin ( Lipitor ) and Simvastatin ( ...
Leggi articolo

Potential risk of meningiomas with high-dose Cyproterone acetate

Cyproterone acetate is a derivative of progesterone, and has progestagenic, antiandrogenic, and antigonadotrophic effects. High-dose preparations available in the UK ...
Leggi articolo

Breast cancer: oligohydramnios associated with Herceptin

Hoffmann-La Roche, in consultation with Health Canada, has informed HealthCare Professionals of important new safety information regarding the use of ...
Leggi articolo

Risk of histoplasmosis and other invasive fungal infections associated with Enbrel

Amgen Canada, on behalf of Immunex, in collaboration with Health Canada, has informed HealthCare Professionals of updated safety information regarding ...
Leggi articolo

ODAC recommends against approving Tarceva for first-line maintenance use in advanced non-small cell lung cancer

OSI Pharmaceuticals and Genentech announced that FDA ( Food and Drug Administration ) Oncologic Drugs Advisory Committee ( ODAC ) ...
Leggi articolo

Kalbitor for treating potentially life-threatening attacks of hereditary angioedema

The FDA ( Food and Drug Administration ) has approved Kalbitor ( Ecallantide ) to treat sudden and potentially life-threatening ...
Leggi articolo

Advanced breast cancer patients: Denosumab is superior to Zometa in reducing risk of developing multiple skeletal related events

In a Phase 3, head-to-head trial of Denosumab versus Zoledronic acid ( Zometa ) in the treatment of bone metastases ...
Leggi articolo

Hepatic effects linked to Voltaren gel

Novartis has informed healthcare professionals regarding changes in the Warnings and Precautions section of the Voltaren Gel ( Diclofenac sodium ...
Leggi articolo

Anticoagulants in the prevention of venous thromboembolism and recurrent miscarriage

Coagulation is an important process that prevents excessive bleeding when a blood vessel is injured. Sometimes, however, clots form on ...
Leggi articolo

Dronedarone: benefit risk assessment

Dronedarone ( Multaq ) is indicated for rhythm and rate control in patients with atrial fibrillation ( AF ) / ...
Leggi articolo

Safety questions on Sibutramine, an appetite suppressant

The FDA ( Food and Drug Administration ) is reviewing preliminary data from a recent study suggesting that patients using ...
Leggi articolo

Caution should be exercised when using non-steroidal anti-inflammatory drugs in patients with established, or a risk of, renal impairment

Non-steroidal anti-inflammatory drugs ( NSAIDs, including COX-2 inhibitors ) may rarely precipitate renal failure, and vulnerable ( particularly elderly ) patients ...
Leggi articolo

Influenza: safety information on Tamiflu and Relenza

Tamiflu ( Oseltamivir ) and Relenza ( Zanamivir ) are both neuraminidase enzyme inhibitors. They act by inhibiting entry of ...
Leggi articolo

Plavix: avoid use with Omeprazole

The FDA ( Food and Drug Administration ) has warned to avoid using the stomach acid reducer Omeprazole ( Prilosec ...
Leggi articolo

ACE inhibitors and angiotensin II receptor antagonists: recommendations on use during pregnancy and breastfeeding

Angiotensin converting enzyme ( ACE ) inhibitors and angiotensin II receptor antagonists ( sartans ) are licensed for a range ...
Leggi articolo

Severe hypersensitivity reactions during infusion of Temsirolimus

Temsirolimus (Torisel ) is an antineoplastic agent used to treat patients with advanced renal-cell carcinoma who have at least three ...
Leggi articolo

Antiepileptics: adverse effects on bone

The antiepileptic drugs Carbamazepine, Phenytoin, Primidone, and Phenobarbital are known to cause osteomalacia, and the product information for healthcare professionals for ...
Leggi articolo

Altered kidney function in patients using Byetta

The FDA ( Foodand Drug Administration ) has approved revisions to the drug label for Byetta ( Exenatide) to include ...
Leggi articolo

Kidney failure linked to Byetta, a drug for type 2 diabetes mellitus

The FDA ( Food and Drug Administration ) has completed a review of 78 cases of altered kidney function reported ...
Leggi articolo

Movement disorders linked to Metoclopramide

The selective D2 dopamine receptor antagonist Metoclopramide is an antiemetic and antinauseant, available in several branded oral or injectable formulations ...
Leggi articolo

Celtura, a cell culture-based influenza A/H1N1 pandemic vaccine

Novartis announced that it received approval from the German regulatory authorities for its adjuvanted cell culture-based Influenza A/H1N1 2009 monovalent ...
Leggi articolo

Diabetes: possible link between Lantus and cancer

The European Association for the Study of Diabetes ( EASD ) made an urgent call for more research into a ...
Leggi articolo

Rheumatoid arthritis: Rituximab linked to progressive multifocal leukoencephalopathy

A third case of progressive multifocal leukoencephalopathy ( PML ) has been reported in a patient with rheumatoid arthritis treated ...
Leggi articolo

Chronic lymphocytic leukaemia: FDA has approved Arzerra

The FDA ( Food and Drug Administration ) has approved Arzerra ( Ofatumumab ) for patients with chronic lymphocytic leukemia ...
Leggi articolo

Advanced form of kidney cancer: Votrient approved

The FDA ( Food and Drug Administration ) has approved Votrient ( Pazopanib ), the sixth drug to be approved ...
Leggi articolo

Heterozygous familial hypercholesterolemia: Crestor for use in pediatric patients

The FDA ( Food and Drug Administration ) has approved Crestor ( Rosuvastatin calcium ) for use in pediatric patients ...
Leggi articolo

New indication for Gardasil: to prevent condyloma acuminata in men and boys

The FDA ( Food and Drug Administration ) has approved use of the vaccine Gardasil for the prevention of genital ...
Leggi articolo

Ongoing safety review of Exjade

The FDA ( Food and Drug Administration ) is reviewing adverse event information for Exjade ( Deferasirox ) from a ...
Leggi articolo

Hereditary angioedema: Berinert to treat abdominal attacks, facial swelling

The FDA ( Food and Drug Administration ) has approved Berinert, the first treatment for acute abdominal attacks and facial ...
Leggi articolo

Endothelin receptor antagonists: Darusentan for treatment of resistant hypertension

DAR-311, a Phase III clinical trial evaluating the endothelin receptor antagonist ( ERA ) Darusentan for the treatment of resistant ...
Leggi articolo

Antiepilepsy drugs: Valproate linked to risk on cognitive function for unborn children

Interim results of a study being conducted by scientists at the University of Liverpool suggest that children aged three years ...
Leggi articolo

Diabetes mellitus of type 2: Januvia and Janumet linket to acute pancreatitis

The FDA ( Food and Drug Administration ) has completed a review of 88 cases of acute pancreatitis in patients ...
Leggi articolo

Intelence linked to severe skin reactions

Tibotec Therapeutics, in cooperation with FDA ( Food and Drug Administration ), has informed healthcare professionals of an important safety ...
Leggi articolo

EU: withdrawal of the marketing authorisations for medicines containing Dextropropoxyphene

The EMEA ( European Medicines Agency ) has completed a review of the safety and effectiveness of Dextropropoxyphene-containing medicines. The ...
Leggi articolo

Saphris for treating schizophrenia and bipolar disorder: FDA has approved

The FDA ( Food and Drug Administration ) has approved Saphris tablets ( Asenapine ) to treat adults with schizophrenia, ...
Leggi articolo

Antipsychotic drugs: restrictions on use of Clozapine may have caused thousands of extra deaths worldwide in schizophrenia patients

Restrictions on the use of the second-generation antipsychotic drug Clozapine ( Clozaril ), due to safety concerns, may have caused ...
Leggi articolo

Rheumatoid arthritis: Golimumab shows promising results in patients who have poor response to other TNF-alpha inhibitors

Golimumab ( Simponi ), a new tumour necrosis factor-alpha ( TNF-alpha ) blocker reduces the signs and symptoms of rheumatoid ...
Leggi articolo

Rheumatoid arthritis: treatment with the monoclonal anti-TNF-alpha antibodies Adalimumab and Infliximab linked to increased risk for herpes zoster

Use of monoclonal anti-TNF-alpha antibodies for the treatment of rheumatoid arthritis appears to be associated with an increased risk for ...
Leggi articolo

Risk of tuberculosis: higher for patients receiving anti-TNF monoclonal antibody therapy than for those receiving soluble TNF receptor therapy

Treatment with anti-TNF ( tumor necrosis factor ) blockers is recognized as a risk factor for tuberculosis ( TB ) ...
Leggi articolo

Lantus possibly increases cancer risk

The risk of cancer possibly increases if patients with diabetes use the long-acting nsulin analogue Glargine instead of human Insulin. ...
Leggi articolo

TNF blockers linked to increased risk of lymphoma, leukaemia and new-onset psoriasis

The FDA ( Food and Drug Administration ) is requiring the manufacturers of TNF blockers to update the Boxed Warning ...
Leggi articolo

Type II diabetes: pancreatic cancer risk decreased by Metformin, increased by Insulin or insulin secretagogues

The antidiabetic medication Metformin is associated with a reduced risk of pancreatic cancer in diabetics, according to a new study ...
Leggi articolo

Velaglucerase alfa for type 1 Gaucher disease: positive results from first of three phase III trials

Positive results from the first of three Phase III studies of Velaglucerase alfa, an enzyme replacement therapy in development for ...
Leggi articolo

FDA: early communication about safety of Lantus

The FDA ( Food and Drug Administration ) is aware of four recently-published observational studies that looked at the use ...
Leggi articolo

Montelukast linked to suicidality and other psychiatric adverse reactions

Montelukast sodium ( Singulair ), a leukotriene-receptor antagonist, is indicated for the prophylaxis and chronic treatment of asthma in patients ...
Leggi articolo

Serious ocular adverse reactions linked to intravitreal injection of Triamcinolone acetonide

Triamcinolone acetonide is a synthetic corticosteroid primarily used for its marked anti-inflammatory action. In Canada, the 40-mg/mL suspension has been authorized ...
Leggi articolo

Boxed warning for smoking cessation drugs Chantix and Zyban: risk of serious mental health events

The FDA ( Food and Drug Administration ) announced that it is requiring manufacturers to put a Boxed Warning on ...
Leggi articolo

Multaq to maintain normal heart rhythm in patients with atrial fibrillation or atrial flutter: FDA approved

The FDA ( Food and Drug Administration ) has approved Multaq tablets ( Dronedarone ) to help maintain normal heart ...
Leggi articolo

FDA: Alimta as first maintenance therapy for advanced lung cancer

The FDA ( Food and Drug Administration ) has approved Alimta ( Pemetrexed ), the first drug available for maintenance ...
Leggi articolo

Effient to reduce the risk of myocardial infarction in angioplasty: FDA approved

The FDA ( Food and Drug Administration ) has approved the blood-thinning drug Effient tablets ( Prasugrel ) to reduce ...
Leggi articolo

Javlor in metastatic treatment of bladder cancer after failure of a prior Platinum-containing regimen: positive CHMP opinion

The Committee for Medicinal Products for Human Use ( CHMP ), the scientific advisory committee of the European Medicines Agency ...
Leggi articolo

VAERS reports: 28 deaths related to Gardasil in 2008

Judicial Watch has announced that it has obtained records from the FDA ( Food and Drug Administration ) documenting 28 ...
Leggi articolo

Papillomavirus: syncope following vaccination with Gardasil

The FDA ( Food and Drug Administration ) has approved a revised label for Gardasil, a vaccine to protect against ...
Leggi articolo

Multiple sclerosis: Natalizumab promotes remyelination

Results of a study demonstrated that Natalizumab ( Tysabri ) promoted regeneration and stabilization of damage done to the myelin ...
Leggi articolo

Gaucher disease: Genz-112638 meets primary endpoint in a Phase 2 clinical trial

A Phase 2 clinical trial of Genz-112638 for Gaucher disease type 1 met its primary endpoint. Genzyme is developing Genz-112638, a ...
Leggi articolo

Homozygous familial hypercholesterolemia: 25 percent LDL-C reduction with Mipomersen

Mipomersen in patients with homozygous familial hypercholesterolemia ( hoFH ) met its primary endpoint, with a 25 percent reduction in ...
Leggi articolo

Graves’ disease: Propylthiouracil linked to liver failure

The FDA ( Food and Drug Administration ) has informed healthcare professionals of the risk of serious liver injury, including ...
Leggi articolo

Safety and efficacy of Sirolimus as an immunosuppressant have not been established in liver transplant patients

The FDA ( Food and Drug Administration ) has informed healthcare professionals of clinical trial data that suggest increased mortality ...
Leggi articolo

Neuropsychiatric events with leukotriene inhibitors: Montelukast, Zafirlukast and Zileuton

Neuropsychiatric events have been reported in some patients taking Montelukast ( Singulair ), Zafirlukast ( Accolate ), and Zileuton ( ...
Leggi articolo

Avastin for treatment of glioblastoma multiforme

The FDA ( Food and Drug Administration ) has approved Avastin ( Bevacizumab ) to treat patients with glioblastoma multiforme ...
Leggi articolo

Hyponatremia: FDA has approved Samsca

The FDA ( Food and Drug Administration ) has approved Samsca tablets ( Tolvaptan ) to treat hyponatremia associated with ...
Leggi articolo

Gastrointestinal perforation, skin lesions or ocular disorders associated with Tarceva

Genentech and OSI Pharmaceuticals have informed Healthcare Professionals of new safety information regarding Tarceva ( Erlotinib ). Tarceva monotherapy is indicated ...
Leggi articolo

Secondary exposure to Testosterone gel

The FDA ( Food and Drug Administration ) announced that it is requiring manufacturers of two prescription topical testosterone gel ...
Leggi articolo

Inflammatory breast cancer: Lapatinib could be used to treat patients with aggressive form

Lapatinib ( Tykerb ) could be used to treat inflammatory breast cancer, an aggressive from of the disease which represents ...
Leggi articolo

Metastatic HER2+ breast cancer: a combination of Capecitabine, Vinorelbine, and Trastuzumab is promising option

Combining two chemotherapy drugs with Trastuzumab ( Herceptin ) to treat women who have metastatic HER2+ breast cancer may offer ...
Leggi articolo

Bevacizumab effective at delaying alkylator-refractory anaplastic oligodendroglioma progression

The use of Bevacizumab ( Avastin ) alone to treat a subgroup of recurrent grade 3 brain tumors showed it ...
Leggi articolo

Anti-angiogenesis inhibitors may improve outcomes of patients with sex cord-stromal tumors

Researchers at The University of Texas M. D. Anderson Cancer Center have found that increased angiogenesis and vascular endothelial growth ...
Leggi articolo

Rheumatoid arthritis: Anakinra, a modest benefit with some risk

New research supports a modest beneficial effect of Anakinra ( Kineret ) for rheumatoid arthritis patients, but warns against potential ...
Leggi articolo
  • ← Precedente
  • Successivo →

Xagena Search

MedTv
  • Antibiotici nel trattamento della Broncopneumopatia Cronica Ostruttiva riacutizzata
  • Polmoniti comunitarie - Percorso Diagnostico-Terapeutico
  • Terapia Antibiotica per le Infezioni Urinarie Non-Complicate Cistite
  • Sinusiti Mascellari Odontogene
  • Terapia Antibiotica Empirica
  • Linee Guida per il Trattamento delle Sinusiti Batteriche Acute negli Adulti e nei Bambini
  • Ruolo della Betaistina nel trattamento di pazienti con sintomi vertiginose
  • Cosa fare di fronte al paziente che riferisce vertigini?
  • Resistenza batterica agli antibiotici
  • Basi per il corretto impiego degli antibiotici in Medicina Generale
MedVideo
  • Tumore della tiroide avanzato: trattamento target delle fusioni TRK
  • Linee Guida per il Trattamento delle Sinusiti Batteriche Acute negli Adulti e nei Bambini
  • Terapie innovative nelle malattie linfoproliferative: update post ASH 2021
  • Terapie immunologiche nelle neoplasie mieloidi
  • Aggiornamenti da International Myeloma Workshop 2021
  • Ruolo dell'immunoterapia nella prima linea di terapia del NSCLC
  • Resistenza batterica agli antibiotici
  • Basi per il corretto impiego degli antibiotici in Medicina Generale
  • Prospettive nella terapia di prima linea del carcinoma polmonare non a piccole cellule non-oncogene-addicted
  • Covid-19 e neoplasie ematologiche

Xagena Medicina

Chi siamo | Contatti | Mappa Network

Xagena Specialità
  • Allergologia
  • Cardiologia
  • Dermatologia
  • Ematologia
  • Endocrinologia
  • Epatologia
  • Gastroenterologia
  • Ginecologia
  • Infettivologia
  • Metabolismo
  • Nefrologia
  • Neurologia
  • Oftalmologia
  • Oncologia
  • Ortopedia
  • Pediatria
  • Psichiatria
  • Pneumologia
  • Reumatologia
  • Urologia
Xagena Forum
  • Forum Cardiologico
  • Forum Neurologico
  • Forum Oncologico
Xagena Motori di Ricerca Italiano
  • MediExplorer.it
  • FarmaExplorer.it
  • CardioBase.it
  • NeuroBase.it
  • OncoBase.it
Xagena Database Italiano
  • FarmaPedia.it
  • MedFocus.it
  • Mediline.it
  • MedPedia.it
  • Xapedia.it
Xagena Oncologia Hub
  • OncoDermatologia
  • OncoEmatologia
  • OncoGastroenterologia
  • OncoGeriatria
  • OncoGinecologia
  • OncoNeurologia
  • OncoPneumologia
  • OncoTerapia
  • OncoUrologia
Xagena Search Engine English
  • MediExplorer.net
Xagena Database English
  • MedPedia.net
  • Xapedia.net

2000-2025© XAGENA srl - P.IVA: 04454930969 - REA: 1748680 - Tutti i diritti riservati - Disclaimer